RT Journal Article
SR Electronic
T1 Metagenomic sequencing to detect respiratory viruses in persons under investigation for COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.09.20178764
DO 10.1101/2020.09.09.20178764
A1 Ahmed Babiker
A1 Heath L. Bradley
A1 Victoria D. Stittleburg
A1 Autum Key
A1 Colleen S. Kraft
A1 Jesse J. Waggoner
A1 Anne Piantadosi
YR 2020
UL http://medrxiv.org/content/early/2020/09/10/2020.09.09.20178764.abstract
AB We used metagenomic next-generation sequencing (mNGS) to assess the frequencies of alternative viral infections in SARS-CoV-2 RT-PCR negative persons under investigations (PUIs) (n=30) and viral co-infections in SARS-CoV-2 RT-PCR positive PUIs (n=45). mNGS identified both co-infections and alternative viral infections that were not detected by routine clinical workup.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the Pediatric Research Alliance Center for Childhood Infections and Vaccines and Childrens Healthcare of Atlanta. The Yerkes NHP Genomics Core is supported in part by NIH P51 OD011132 and sequencing data was acquired on an Illumina NovaSeq6000 funded by NIH S10 OD026799. Salary support was provided by the Doris Duke Charitable Foundation Clinical Scientist Development Award 2019089 (JJW) and NIH K08 AI139348 (AP).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Emory University IRBAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll reads (cleaned of human reads) will be submitted to the Sequence Read Archive and complete genomes will be submitted to GenBank.